Skip to content
BioLab
Back to Labs
BioLab · research library

Literature Workspace

Explore evidence. Connect research.

References, not copies: every entry links to its original source and keeps where its metadata came from. Reading states organise the library; they are not a judgement of scientific quality.

References
21
Collections
4
Sources
3

MVA Hackathon 2026 — BUB1B · 21 references

Published sources behind the validated MVA · BUB1B evidence snapshot. Each reference is cited by at least one evidence record. Open the research case.

Supplementary audit documentation · October 24, 2026 research revision · 15 files at commit bc39224

Computational audit documents of this collection's research case, linked at a fixed commit of the research repository. They are not references of the library, experiments or an official resubmission, and they are not counted above. They are read in the “Robustness and limits” step of the case trail and on the case page.

Research article 2026 Reviewed MVA Hackathon 2026 — BUB1B

BubR1 TPR domain supports the mitotic checkpoint by promoting MCC formation and MCC-APC/C interaction

Mingzhe Zhang, Tingting Lei, Ying Wang and 4 more Communications Biology

BubR1 is a key component of the mitotic checkpoint, a surveillance mechanism which ensures accurate chromosome segregation by facilitating the assembly of the mitotic checkpoint complex (MCC) and promoting its binding to… abstract via Europe PMC

Evidence snapshot note: BUBR1 TPR / MCC–APC/C functional controls. Model: HeLa endogenous BUBR1 RNAi and RNAi-resistant YFP replacement. Where: Figure 4B; supplementary source-data workbook, Sheet1 · cited by MVA-CTRL-006

  • BubR1
  • tetratricopeptide repeat domain
  • spindle assembly checkpoint
  • mitotic checkpoint complex
Research article 2025 Reviewed MVA Hackathon 2026 — BUB1B

Translational readthrough therapy for ADPKD induces polycystin1 expression and partially rescues functional deficits in PKD1 mutant cells

Elena Torban, Lucie Canaff, Sima Babayeva and 5 more Scientific Reports

Autosomal-Dominant Polycystic Kidney Disease, ADPKD, is the most common genetic kidney disease affecting 1:1000 people worldwide. It is caused by mutations in the PKD1 (~ 80%) or PKD2 gene (~ 15%). Although the germline … abstract via Europe PMC

Evidence snapshot note: Torban et al. — PKD1 readthrough and partial cellular rescue. Model: Human HEK293 PKD1 reporters and WT9-12 cells; other-gene evidence. Where: Figures 1H-I, 4, 5 and 6; published 2025-11-22 · cited by MVA-RT-TRANSFER-009

  • Therapy
  • Aminoglycosides
  • Readthrough Drugs
  • Autosomal-dominant Polycystic Kidney Disease
Research article 2024 Reviewed MVA Hackathon 2026 — BUB1B

Genome-scale quantification and prediction of pathogenic stop codon readthrough by small molecules

Ignasi Toledano, Fran Supek, Ben Lehner Nature Genetics

Abstract Premature termination codons (PTCs) cause ~10–20% of inherited diseases and are a major mechanism of tumor suppressor gene inactivation in cancer. A general strategy to alleviate the effects of PTCs would be to … abstract via Crossref

Evidence snapshot note: Toledano et al. — genome-scale PTC readthrough. Model: Human HEK293T landing-pad reporters; not endogenous BUB1B. Where: Supplementary Table 3; Extended Data Figure 4 · cited by MVA-RT-002

  • nonsense suppression
  • stop codon readthrough
  • premature stop codon
  • nonsense mutation
Research article 2024 Reviewed MVA Hackathon 2026 — BUB1B

Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial

Meenakshi Hegde, Shoba Navai, Christopher DeRenzo and 34 more Nature Cancer

Evidence snapshot note: Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial. Model: People with progressive HER2-positive sarcoma, including rhabdomyosarcoma.. Where: Abstract; Table 1 and response results / Figure 4 located through indexed primary-article text. · cited by MVA-IMMUNE-011

  • HER2
  • chimeric antigen receptor T cells
  • autologous CAR T-cell therapy
  • advanced sarcoma
Research article 2024 Reviewed MVA Hackathon 2026 — BUB1B

Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction

Corina Amor, Inés Fernández-Maestre, Saria Chowdhury and 16 more Nature Aging

Abstract Senescent cells, which accumulate in organisms over time, contribute to age-related tissue decline. Genetic ablation of senescent cells can ameliorate various age-related pathologies, including metabolic dysfunc… abstract via Crossref

Evidence snapshot note: Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction. Model: Naturally aged C57BL/6 mice and high-fat-diet mice.. Where: Figures 3-5 (clearance, safety assessments and metabolic endpoints); Figures 6-7 (persistence/prevention and high-fat diet). · cited by MVA-IMMUNE-011

  • cellular senescence
  • urokinase-type plasminogen activator receptor
  • uPAR
  • exercise capacity
Research article 2023 Reviewed MVA Hackathon 2026 — BUB1B

Amlexanox: Readthrough Induction and Nonsense-Mediated mRNA Decay Inhibition in a Charcot–Marie–Tooth Model of hiPSCs-Derived Neuronal Cells Harboring a Nonsense Mutation in GDAP1 Gene

Nesrine Benslimane, Federica Miressi, Camille Loret and 7 more Pharmaceuticals

Nonsense mutations are involved in multiple peripheral neuropathies. These mutations induce the presence of a premature termination codon (PTC) at the mRNA level. As a result, a dysfunctional or truncated protein is synt… abstract via Crossref

Evidence snapshot note: Amlexanox in GDAP1 neuronal progenitors. Model: Human iPSC-derived neuronal progenitors with GDAP1 p.Ser194* (UGA). Where: Figures 2-4 · cited by MVA-AMLEXANOX-010

  • Cmt Disease
  • Nonsense Mutation
  • Premature Termination Codon (Ptc)
  • Nonsense-mediated Decay (Nmd)
Research article 2022 Reviewed MVA Hackathon 2026 — BUB1B

A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412

Kara L. Davis, Elizabeth Fox, Emasenyie Isikwei and 7 more Clinical Cancer Research

PURPOSE: In many cancers, nivolumab in combination with ipilimumab improves response rates compared with either agent alone, but the combination has not been evaluated in childhood cancer. We conducted a phase I/II trial… abstract via OpenAlex

Evidence snapshot note: A Phase I/II Trial of Nivolumab Plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: ADVL1412. Model: Children and young adults with recurrent/refractory solid tumors.. Where: Abstract reproduced by the investigators at Children's Oncology Group; Figure 3A located in indexed primary text. · cited by MVA-IMMUNE-011

  • nivolumab
  • ipilimumab
  • immune checkpoint inhibitors
  • combination immunotherapy
Research article 2022 Reviewed MVA Hackathon 2026 — BUB1B

Quantitative Comparison of HSF1 Activators

Christoph Steurer, Sarah Kerschbaum, Christina Wegrostek and 5 more Molecular Biotechnology

Abstract The heat shock response (HSR) pathway is a highly conserved rescue mechanism, which protects the cells from harmful insults disturbing the cellular protein homeostasis via expression of chaperones. Furthermore, … abstract via Crossref

Evidence snapshot note: Steurer et al. — HSF1 reporter evaluation. Model: Human HSF-responsive reporter and endogenous target systems. Where: Table 1 and Figure 4: negative arimoclomol response in this system · cited by MVA-ARI-007

  • Heat shock response
  • Neurodegenerative disease
  • Luciferase assay
  • Hsf1
Research article 2022 Reviewed MVA Hackathon 2026 — BUB1B

NanoLuc reporters identify COL4A5 nonsense mutations susceptible to drug-induced stop codon readthrough

Kohei Omachi, Hirofumi Kai, Michel Roberge, Jeffrey H. Miner iScience

Alport syndrome, a disease of kidney, ear, and eye, is caused by pathogenic variants in the COL4A3 , COL4A4 , or COL4A5 genes encoding collagen α3α4α5(IV) of basement membranes. Collagen IV chains that are truncated due … abstract via Europe PMC

Evidence snapshot note: Omachi et al. — COL4A5 readthrough reporters. Model: HEK293 COL4A5 cDNA reporters; different gene and context. Where: Figure 6: gentamicin plus mefloquine · cited by MVA-RT-002

  • Molecular biology
  • Biochemistry
  • Molecular Medicine
Research article 2022 Reviewed MVA Hackathon 2026 — BUB1B

Molecular profiling of individual FDA-approved clinical drugs identifies modulators of nonsense-mediated mRNA decay

Jingrong Zhao, Zhelin Li, Ruchira Puri and 4 more Molecular Therapy Nucleic Acids

Nonsense-mediated mRNA decay (NMD) degrades transcripts with premature stop codons. Given the prevalence of nonsense single nucleotide polymorphisms (SNPs) in the general population, it is urgent to catalog the effects o… abstract via Europe PMC

Evidence snapshot note: Zhao et al. — molecular profiling of NMD modulators. Model: Mouse Neuro-2a; three AS-NMD isoform reporters. Where: Tables S1/S2/S4; Figures 2–5 and 7 · cited by MVA-NMD-003, MVA-AMLEXANOX-010

  • Mitoxantrone
  • artesunate
  • albendazole
  • Gabexate Mesilate
Research article 2022 Reviewed MVA Hackathon 2026 — BUB1B

Neurofilament Light Regulates Axon Caliber, Synaptic Activity, and Organelle Trafficking in Cultured Human Motor Neurons

Markus T. Sainio, Tiina Rasila, Svetlana M. Molchanova and 12 more Frontiers in Cell and Developmental Biology

Neurofilament light (NFL) is one of the proteins forming multimeric neuron-specific intermediate filaments, neurofilaments, which fill the axonal cytoplasm, establish caliber growth, and provide structural support. Domin… abstract via Crossref

Evidence snapshot note: NEFL motor-neuron negative rescue. Model: Human iPSC-derived NEFL nonsense motor neurons. Where: Figure 6; Treatments · cited by MVA-AMLEXANOX-010

  • Axon
  • Induced Pluripotent Stem Cells
  • Charcot-marie-tooth (Cmt) Disease
  • Neurofilament Light (Nfl)
Research article 2020 Reviewed MVA Hackathon 2026 — BUB1B

Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1–2 trial

Kara L Davis, Elizabeth Fox, Melinda S Merchant and 8 more The Lancet Oncology

Evidence snapshot note: Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412). Model: Pediatric and young-adult relapsed/refractory malignancies; phase 1-2.. Where: Abstract, findings and interpretation; no figure-level extraction. · cited by MVA-IMMUNE-011

  • PD-1 inhibitors
  • childhood cancer
  • lymphoma
  • rhabdomyosarcoma
Research article 2019 Reviewed MVA Hackathon 2026 — BUB1B

BubR1 allelic effects drive phenotypic heterogeneity in mosaic-variegated aneuploidy progeria syndrome

Cynthia J. Sieben, Karthik B. Jeganathan, Grace G. Nelson and 8 more Journal of Clinical Investigation

Mosaic-variegated aneuploidy (MVA) syndrome is a rare childhood disorder characterized by biallelic BUBR1, CEP57, or TRIP13 aberrations; increased chromosome missegregation; and a broad spectrum of clinical features, inc… abstract via OpenAlex

Evidence snapshot note: Sieben et al. — allelic effects in MVA progeria syndrome. Model: Mouse BubR1 L1002P ortholog model of human L1012P with hypomorphic or truncating alleles. Where: Abstract and Figures 1-3; related variant, not N1002K · cited by MVA-N1002K-GATE-002

  • Aging
  • Cancer
  • Cellular senescence
  • Oncology
Research article 2016 Reviewed MVA Hackathon 2026 — BUB1B

Induction of heat shock proteins in differentiated human neuronal cells following co-application of celastrol and arimoclomol

Catherine A.S. Deane, Ian R. Brown Cell Stress and Chaperones

Few effective therapies exist for the treatment of neurodegenerative diseases that have been characterized as protein misfolding disorders. Upregulation of heat shock proteins (Hsps) mitigates against the accumulation of… abstract via OpenAlex

Evidence snapshot note: Deane and Brown — conditional heat-shock co-induction. Model: Differentiated human SH-SY5Y cells; arimoclomol plus celastrol. Where: Figures 2–5; not a BUBR1 study · cited by MVA-ARI-007

  • Heat shock
  • Celastrol
  • Arimoclomol
  • Hspa1a (Hsp70-1)
Research article 2015 Reviewed MVA Hackathon 2026 — BUB1B

Rapamycin reduces fibroblast proliferation without causing quiescence and induces STAT5A/B-mediated cytokine production

Zoe E Gillespie, Kimberly MacKay, Michelle Sander and 10 more Nucleus

Rapamycin is a well-known inhibitor of the Target of Rapamycin (TOR) signaling cascade; however, the impact of this drug on global genome function and organization in normal primary cells is poorly understood. To explore… abstract via OpenAlex

Evidence snapshot note: Gillespie et al. — rapamycin and normal human fibroblast transcription. Model: 2DD normal human foreskin fibroblasts; two biological replicates per condition. Where: GSE65145 processed tracks; Figures 1 and 3; Figure S2; Cell culture and RNA-seq methods · cited by MVA-RAP-GSE65145-001

  • Quiescence
  • Rapamycin
  • Rna-seq
  • Primary Fibroblast
Research article 2013 Reviewed MVA Hackathon 2026 — BUB1B

BUBR1 recruits PP2A via the B56 family of targeting subunits to promote chromosome congression

Peng Xu, Elizabeth A. Raetz, Mayumi Kitagawa and 2 more Biology Open

Summary BUBR1 is a mitotic phosphoprotein essential for the maintenance of chromosome stability by promoting chromosome congression and proper kinetochore–microtubule (K-fiber) attachment, but the underlying mechanism(s)… abstract via Crossref

Evidence snapshot note: Xu et al. — BUBR1 recruits PP2A-B56 for chromosome congression. Model: HeLa BUBR1 depletion/reconstitution and BUB1B-mutated MVA fibroblast rescue. Where: Figures 2 and 4; equally expressed B56-binding mutants are functional counterexamples · cited by MVA-N1002K-GATE-002

  • Chromosome Congression
  • Bubr1
  • Aurora B
  • B56-pp2a
Research article 2012 Reviewed MVA Hackathon 2026 — BUB1B

Rescue of nonsense mutations by amlexanox in human cells

Sara Gonzalez-Hilarion, Terence Beghyn, Jieshuang Jia and 7 more Orphanet Journal of Rare Diseases

Background Nonsense mutations are at the origin of many cancers and inherited genetic diseases. The consequence of nonsense mutations is often the absence of mutant gene expression due to the activation of an mRNA survei… abstract via Europe PMC

Evidence snapshot note: Amlexanox rescue in human cells. Model: Human 6CFSMEo- CFTR nonsense cells. Where: Figure 6 · cited by MVA-AMLEXANOX-010

  • amlexanox
  • nonsense mutation
  • nonsense-mediated mRNA decay
  • genetic disorders
Research article 2011 Reviewed MVA Hackathon 2026 — BUB1B

Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders

Darren J. Baker, Tobias Wijshake, Tamar Tchkonia and 5 more Nature

Evidence snapshot note: Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Model: BubR1 H/H hypomorphic progeroid mice carrying INK-ATTAC.. Where: Abstract; Figures 2-4 public captions. · cited by MVA-IMMUNE-011

  • cellular senescence
  • senolytics
  • senolytic therapy
  • p16INK4a
Research article 2010 Reviewed MVA Hackathon 2026 — BUB1B

Molecular Causes for BUBR1 Dysfunction in the Human Cancer Predisposition Syndrome Mosaic Variegated Aneuploidy

Saskia J.E. Suijkerbuijk, Maria H.J. van Osch, Frank L. Bos and 3 more Cancer Research

Genetic mutations in the mitotic regulatory kinase BUBR1 are associated with the cancer-susceptible disorder mosaic variegated aneuploidy (MVA). In patients with biallelic mutations, a missense mutation pairs with a trun… abstract via OpenAlex

Evidence snapshot note: Suijkerbuijk et al. — molecular causes of BUBR1 dysfunction. Model: U2OS/HeLa BUBR1 depletion and replacement. Where: Figures 4D and 5; comparator variants, not N1002K · cited by MVA-N1002K-GATE-002, MVA-L737-NMD-FIRST-001

  • BubR1
  • spindle assembly checkpoint
  • biallelic variants
  • missense mutations
Document Reviewed MVA Hackathon 2026 — BUB1B

FDA historical Aphthasol label

www.accessdata.fda.gov

Evidence snapshot note: FDA historical Aphthasol label. Model: Historical FDA Aphthasol 5% oral-paste label. Where: Pharmacokinetics and Metabolism, page 1 · cited by MVA-AMLEXANOX-010

Researcher sign-in

Sign in with your Stackfire account to save references, build collections and tag the library. Reading is open to everyone.

Add reference

Paste a DOI, PMID, PMCID, NCT number or a URL that carries one. Metadata is fetched from the public sources and shown before anything is saved.

New collection

Edit

KBot · Research guide

Prewritten answers · Evidence linked

KBot

Hello, I am KBot, the BioLab research guide. I can explain the research cases, the Literature Workspace, the Evidence Graph and the analysis tools, and where each one stops. Choose a topic below. These are prewritten explanations, not a live AI consultation.

Research information, not individual medical advice. No messages are sent or saved.